AI could predict heart and artery risks before they happen

NCT ID NCT07187700

Not yet recruiting Knowledge-focused Sponsor: Amsterdam UMC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study will collect data from 1100 people with peripheral artery disease or abdominal aortic aneurysm across six European centers. Researchers will use artificial intelligence to analyze clinical data, blood samples, imaging, and wearable device information to build tools that predict disease progression and heart-related risks. The goal is to help doctors personalize treatment and reduce serious complications like heart attack or amputation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to AI tools that help doctors predict which patients are at high risk of complications, enabling earlier and more personalized treatment.
What could go wrong: This is an observational study that only develops and tests prediction models, not a treatment. The AI tools may not prove accurate enough for real-world use, and results may take years to validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTA ANEURISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm Disease Progression peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL AORTA ANEURISM PERIPHERAL ARTERIAL DISEASE

More trials for these conditions

Other studies related to the condition(s) this trial covers.